Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics

Out of Stock

Price data last checked 135 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 135 days. Could come back at any time — we're watching for you.

Out of stock 135 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
03 May 2024

Similar Products You Might Like

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
98% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 10 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
97% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 08 Feb 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 13 Jan 2026
The 2025-2030 World Outlook for Blood Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Blood Cancer Therapeutics

Out of Stock 23 Jan 2026
The 2025-2030 World Outlook for Cancer Therapies
97% match

The 2025-2030 World Outlook for Cancer Therapies

Out of Stock 22 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India

£515.00 24 Jan 2026
The 2021-2026 World Outlook for Hematology and Oncology Products
97% match

The 2021-2026 World Outlook for Hematology and Oncology Products

£795.00 14 Jan 2026
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
97% match

The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£795.00 25 Feb 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 13 Jan 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
97% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Out of Stock 31 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

£520.00 11 Jan 2026
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
97% match

The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies

£885.00 11 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India

£515.00 25 Jan 2026
The 2025-2030 World Outlook for Immune-Oncology Treatments
97% match

The 2025-2030 World Outlook for Immune-Oncology Treatments

£790.00 26 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
97% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 14 Apr 2026
The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City

£795.00 13 Jan 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2025-2030 World Outlook for Cancer Biomarkers
97% match

The 2025-2030 World Outlook for Cancer Biomarkers

Out of Stock 27 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026